EZH2 is a potential prognostic predictor of glioma.
Saved in:
| Title: | EZH2 is a potential prognostic predictor of glioma. |
|---|---|
| Authors: | Chen YN; Department of Neurosurgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China., Hou SQ; Department of Neurosurgery, Chuzhou Clinical College of Anhui Medical University, The First People's Hospital Chuzhou, Chuzhou, China., Jiang R; Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair and Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China., Sun JL; Department of Neurosurgery, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hosipital, Shanghai, China., Cheng CD; Department of Neurosurgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China., Qian ZR; Department of Neurosurgery, The First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, Hefei, China. |
| Source: | Journal of cellular and molecular medicine [J Cell Mol Med] 2021 Jan; Vol. 25 (2), pp. 925-936. Date of Electronic Publication: 2020 Dec 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
